A detailed history of Farther Finance Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 20 shares of NTRA stock, worth $3,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 24 16.67%
Holding current value
$3,500
Previous $2.59 Million 1.89%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$97.75 - $129.67 $391 - $518
-4 Reduced 16.67%
20 $2.54 Million
Q2 2024

Jul 31, 2024

BUY
$85.28 - $112.6 $426 - $563
5 Added 26.32%
24 $2.59 Million
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $769 - $1,207
13 Added 216.67%
19 $1.77 Million
Q3 2023

Nov 13, 2023

BUY
$43.4 - $62.52 $477 - $687
11 Added 183.33%
17 $752,000
Q1 2023

May 13, 2024

SELL
$36.57 - $58.29 $402 - $641
-11 Reduced 64.71%
6 $333,000
Q4 2022

Sep 11, 2023

BUY
$34.17 - $47.91 $205 - $287
6 New
6 $241,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $17B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.